i would now like to give the floor to irina nikolaevna isaakova sevak, representative of the almazov centermedical centers in the country, you worked for a long time in atlanta, in georgia, and now you are doing very interesting things. such a classical scheme that, within the framework of such a small youth scientific group, we developed a concept of how to design vaccines, where, what to integrate so as to obtain such combined drugs, at the very next stage, with the assistance of our commercial partner, technological partner, this is the biotechnological company biocad, i think, a well-known company, and we have already received support within the framework of a world-class laboratory for the actual development of such a vaccine, this has just begun, the coronavirus pandemic has begun, it is important that i say here that we are not we’re just developing the drug as such, and many people are developing different drugs, and we’re also doing something, developing production technology, because we know that all influenza vaccines, for example, are now produced on chicken embryos, so there wa